|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/14 | |
| C07K 1/34 | |||
| C07K 1/36 | |||
| C07K 16/30 |
| (11) | Patento numeris | 3172220 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15750191.7 |
| Europos patento paraiškos padavimo data | 2015-07-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/042241 |
| Data | 2015-07-27 |
| (87) | Numeris | WO 2016/015048 |
| Data | 2016-01-28 |
| (30) | Numeris | Data | Šalis |
| 201462028994 P | 2014-07-25 | US |
| (72) |
MEH, David, US
ATOLAGBE, Timothy, US
FARQUHARSON, G. Mark, US
SHABAN, Samir, US
KOLECK, Mary, US
MITRA, George, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street, Silver Spring, MD 20910,
US
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | METHOD FOR PURIFYING ANTIBODIES |
| METHOD FOR PURIFYING ANTIBODIES |